Lindsey S. Treviño, Ph.D. is an Assistant Professor in the Division of Health Equities and the Department of Population Sciences at City of Hope. Dr. Treviño received her doctorate in Reproductive Physiology from Cornell University, where she focused on the role of steroid hormone receptor signaling in the development/progression of ovarian cancer in the hen. Dr. Treviño continued her postgraduate training at Baylor College of Medicine, where she investigated the regulation of progesterone receptor activity by cell signaling pathways in breast cancer cells. She received additional postdoctoral training at the Institute of Biosciences and Technology of Texas A&M University, where she examined how developmental exposure to the endocrine disruptor bisphenol A (BPA) reprograms the liver epigenome to alter liver metabolism in adulthood in the rat. She continued this line of research as an Instructor at Baylor College of Medicine before joining City of Hope. Dr. Treviño’s current research focuses on understanding the molecular basis by which endocrine disruptor exposure promotes the development of metabolic diseases with known disparities, such as cancer, obesity and diabetes. Dr. Treviño has been selected as a Future Leaders Advancing Research in Endocrinology (FLARE) Fellow, a Keystone Symposia Fellow, a National Institutes of Health Future Research Leader, and as a recipient of the Young Investigator Award sponsored by the Women in Endocrinology. She previously served on the Committee on Diversity and Inclusion (CODI), the Research Affairs Core Committee (RACC), and the Governance Task Force of the Endocrine Society.